Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cyril Thouverey

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Bonekey Reports|November 21, 2015
Sclerostin inhibits osteoblast differentiation without affecting BMP2/SMAD1/5 or Wnt3a/β-catenin signaling but through activation of platelet-derived growth factor receptor signaling in vitroCyril Thouverey, Joseph Caverzasio
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 9, 2015
Suppression of p38α MAPK Signaling in Osteoblast Lineage Cells Impairs Bone Anabolic Action of Parathyroid HormoneCyril Thouverey, Joseph Caverzasio
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|April 8, 2011
Activation of FGF receptors is a new mechanism by which strontium ranelate induces osteoblastic cell growthJoseph Caverzasio, Cyril Thouverey
Bonekey Reports|July 2, 2015
Focus on the p38 MAPK signaling pathway in bone development and maintenanceCyril Thouverey, Joseph Caverzasio
Cellular and Molecular Life Sciences : CMLS|April 25, 2012
The p38α MAPK positively regulates osteoblast function and postnatal bone acquisitionCyril Thouverey, Joseph Caverzasio
Endocrinology|October 7, 2015
Ablation of p38α MAPK Signaling in Osteoblast Lineage Cells Protects Mice From Bone Loss Induced by Estrogen DeficiencyCyril Thouverey, Joseph Caverzasio
Bone|May 12, 2018
Selective inhibition of Src family kinases by SU6656 increases bone mass by uncoupling bone formation from resorption in miceCyril Thouverey, Serge Ferrari, Joseph Caverzasio
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 29, 2012
Predominant role of PDGF receptor transactivation in Wnt3a-induced osteoblastic cell proliferationJoseph Caverzasio, Emmanuel Biver, Cyril Thouverey
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 17, 2026
Mechanisms Underlying the Waning of Osteoanabolic Therapy Effects in OsteoporosisSerge Ferrari, Cyril Thouverey, Maude Gerbaix
Molecular and Cellular Endocrinology|September 25, 2013
Crosstalk between tyrosine kinase receptors, GSK3 and BMP2 signaling during osteoblastic differentiation of human mesenchymal stem cellsEmmanuel Biver, Cyril Thouverey, David Magne, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Bonekey Reports|November 21, 2015
Sclerostin inhibits osteoblast differentiation without affecting BMP2/SMAD1/5 or Wnt3a/β-catenin signaling but through activation of platelet-derived growth factor receptor signaling in vitroCyril Thouverey, Joseph Caverzasio
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 9, 2015
Suppression of p38α MAPK Signaling in Osteoblast Lineage Cells Impairs Bone Anabolic Action of Parathyroid HormoneCyril Thouverey, Joseph Caverzasio
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|April 8, 2011
Activation of FGF receptors is a new mechanism by which strontium ranelate induces osteoblastic cell growthJoseph Caverzasio, Cyril Thouverey
Bonekey Reports|July 2, 2015
Focus on the p38 MAPK signaling pathway in bone development and maintenanceCyril Thouverey, Joseph Caverzasio
Cellular and Molecular Life Sciences : CMLS|April 25, 2012
The p38α MAPK positively regulates osteoblast function and postnatal bone acquisitionCyril Thouverey, Joseph Caverzasio
Endocrinology|October 7, 2015
Ablation of p38α MAPK Signaling in Osteoblast Lineage Cells Protects Mice From Bone Loss Induced by Estrogen DeficiencyCyril Thouverey, Joseph Caverzasio
Bone|May 12, 2018
Selective inhibition of Src family kinases by SU6656 increases bone mass by uncoupling bone formation from resorption in miceCyril Thouverey, Serge Ferrari, Joseph Caverzasio
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 29, 2012
Predominant role of PDGF receptor transactivation in Wnt3a-induced osteoblastic cell proliferationJoseph Caverzasio, Emmanuel Biver, Cyril Thouverey
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 17, 2026
Mechanisms Underlying the Waning of Osteoanabolic Therapy Effects in OsteoporosisSerge Ferrari, Cyril Thouverey, Maude Gerbaix
Molecular and Cellular Endocrinology|September 25, 2013
Crosstalk between tyrosine kinase receptors, GSK3 and BMP2 signaling during osteoblastic differentiation of human mesenchymal stem cellsEmmanuel Biver, Cyril Thouverey, David Magne, et al.
Pageof 2